[Problems of resistance in Streptococcus pneumoniae]

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Context:

• Increasing global prevalence of penicillin-resistant Streptococcus pneumoniae strains.
• Challenges in empirical antibiotic therapy for otitis media and meningitis in affected regions.
• The Netherlands and some European countries have been relatively spared from widespread resistance.

Purpose:

• To discuss the implications of penicillin-resistant pneumococci on clinical practice.
• To review treatment strategies for infections caused by resistant strains.
• To highlight the role of vaccines in managing resistant pneumococcal infections.

Summary:

• Penicillin-resistant pneumococci present a growing worldwide health concern, complicating the empirical treatment of common infections like otitis media and meningitis.
• While specialized antibiotics or combinations may be required for severe infections, pneumococcal pneumonia can often be successfully treated with high-dose benzylpenicillin or cephalosporins.
• Importantly, antibiotic resistance is limited to specific pneumococcal strains, which are fortunately included in available antipneumococcal vaccines, offering a protective measure.

Impact:

• Vaccination strategies can mitigate the impact of antibiotic resistance by targeting prevalent resistant strains.
• Understanding resistance patterns is crucial for optimizing treatment guidelines and preventing therapeutic failures.
• Continued surveillance and research are necessary to monitor the evolution of pneumococcal resistance and inform public health interventions.